Who owns TG THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TGTX from SEC Form 13F filings across 432 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 432 institutions disclosed 111.1M shares of TG THERAPEUTICS, INC. worth $6.10B — about 78.3% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
432
13F holders
$6.10B
value, 2026 filers
78.3%
of shares outstanding (111.1M sh)
113
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TGTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 22.1M | $1.21B | 0.0% | 15.6% | -0.9% |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.0M | $437.5M | 0.0% | 5.6% | -3.8% |
| 3 | STATE STREET CORP | 7.8M | $427.8M | 0.0% | 5.5% | -10.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 6.1M | $337.8M | 0.0% | 4.3% | -6.9% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 3.6M | $200.1M | 0.0% | 2.6% | +4.1% |
| 6 | D. E. Shaw & Co., Inc. | 3.4M | $186.8M | 0.1% | 2.4% | +476.4% |
| 7 | Soleus Capital Management, L.P. | 2.9M | $160.9M | 5.5% | 2.1% | -27.3% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.8M | $152.1M | 0.0% | 2% | +337.4% |
| 9 | Clearbridge Investments, LLC | 2.7M | $145.6M | 0.1% | 1.9% | -17.5% |
| 10 | CONGRESS ASSET MANAGEMENT CO | 2.6M | $142.9M | 0.9% | 1.8% | +19.9% |
| 11 | TWO SIGMA INVESTMENTS, LP | 2.5M | $135.6M | 0.1% | 1.7% | +60.1% |
| 12 | GOLDMAN SACHS GROUP INC | 2.3M | $127.1M | 0.0% | 1.6% | +1.2% |
| 13 | Pictet Asset Management Holding SA | 1.8M | $98.1M | 0.1% | 1.3% | +2.2% |
| 14 | JANE STREET GROUP, LLC | 1.8M | $96.3M | 0.0% | 1.2% | -14.2% |
| 15 | Nuveen, LLC | 1.6M | $89.3M | 0.0% | 1.1% | +12.4% |
| 16 | MORGAN STANLEY | 1.6M | $88.0M | 0.0% | 1.1% | +13.7% |
| 17 | Hood River Capital Management LLC | 1.6M | $87.9M | 0.6% | 1.1% | +2.0% |
| 18 | NORTHERN TRUST CORP | 1.5M | $84.4M | 0.0% | 1.1% | +6.5% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.3M | $72.1M | 0.0% | 0.9% | +1.4% |
| 20 | BANK OF AMERICA CORP /DE/ | 1.3M | $72.0M | 0.0% | 0.9% | -10.4% |
| 21 | DIMENSIONAL FUND ADVISORS LP | 1.2M | $66.5M | 0.0% | 0.9% | +11.6% |
| 22 | FMR LLC | 1.0M | $56.0M | 0.0% | 0.7% | +263.3% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 961,750 | $52.8M | 0.0% | 0.7% | -0.7% |
| 24 | BARCLAYS PLC | 957,848 | $52.6M | 0.0% | 0.7% | +721.1% |
| 25 | Bank of New York Mellon Corp | 900,482 | $49.5M | 0.0% | 0.6% | +1.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.